COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review

S Poenaru, SJ Abdallah… - Therapeutic …, 2021 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19) is a viral infection which can cause a variety of
respiratory, gastrointestinal, and vascular symptoms. The acute illness phase generally lasts …

Low cardiorespiratory fitness post-COVID-19: a narrative review

F Schwendinger, R Knaier, T Radtke… - Sports Medicine, 2023 - Springer
Patients recovering from COVID-19 often report symptoms of exhaustion, fatigue and
dyspnoea and present with exercise intolerance persisting for months post-infection …

Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 ' …

E Wood, KH Hall, W Tate - Chronic diseases and translational …, 2021 - mednexus.org
A significant number of SARS-CoV-2 (COVID-19) pandemic patients have developed
chronic symptoms lasting weeks or months which are very similar to those described for …

[HTML][HTML] Mitochondrial dysfunction and coenzyme Q10 supplementation in post-viral fatigue syndrome: an overview

D Mantle, IP Hargreaves, JC Domingo… - International Journal of …, 2024 - mdpi.com
Post-viral fatigue syndrome (PVFS) encompasses a wide range of complex neuroimmune
disorders of unknown causes characterised by disabling post-exertional fatigue, myalgia …

[HTML][HTML] Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome

OA Sukocheva, R Maksoud, NM Beeraka… - Journal of advanced …, 2022 - Elsevier
Background The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) disease
(COVID-19) triggers the development of numerous pathologies and infection-linked …

[HTML][HTML] Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?

PL Toogood, DJ Clauw, S Phadke, D Hoffman - Pharmacological Research, 2021 - Elsevier
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic debilitating
disease characterized by severe and disabling fatigue that fails to improve with rest; it is …

[HTML][HTML] Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID …

AM Chaves-Filho, O Braniff, A Angelova, Y Deng… - Brain Research …, 2023 - Elsevier
After five waves of coronavirus disease 2019 (COVID-19) outbreaks, it has been recognized
that a significant portion of the affected individuals developed long-term debilitating …

Functional and morphological differences of muscle mitochondria in chronic fatigue syndrome and post-COVID syndrome

DA Bizjak, B Ohmayer, JL Buhl, EM Schneider… - International Journal of …, 2024 - mdpi.com
Patients suffering from chronic fatigue syndrome (CFS) or post-COVID syndrome (PCS)
exhibit a reduced physiological performance capability. Impaired mitochondrial function and …

[HTML][HTML] A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome

F Hoel, A Hoel, IKN Pettersen, IG Rekeland, K Risa… - JCI insight, 2021 - ncbi.nlm.nih.gov
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease
usually presenting after infection. Emerging evidence supports that energy metabolism is …

Focus on post-exertional malaise when approaching ME/CFS in specialist healthcare improves satisfaction and reduces deterioration

MEA Wormgoor, SC Rodenburg - Frontiers in neurology, 2023 - frontiersin.org
Background Post-exertional malaise (PEM) is considered a hallmark characteristic of
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This may also apply to …